Chamomile: An anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity

International Journal of Molecular Medicine

Volumn 26, Issue 6, 2010, Pages 935-940

  Bhaskaran, Natarajan ^a,b   Shukla, Sanjeev ^a,b   Srivastava, Janmejai K ^c   Gupta, Sanjay ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c AMITY UNIVERSITY   (India)

Author keywords

Chamomile; Inflammation; Macrophages; Nitric oxide; Nuclear factor B; Pro inflammatory cytokines

Indexed keywords

CHAMOMILE; I KAPPA B KINASE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DNA BINDING; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE; CHAMOMILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE EXPRESSION REGULATION; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; TRANSCRIPTION FACTOR RELA;

EID: 78649917223     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000545     Document Type: Article

References (31)

1. Fujihara M, Muroi M, Tanamoto K, et al: Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194, 2003. (Pubitemid 37377912)
2. Ahn KS, Noh EJ, Zhao HL, et al: Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappa B activation in RAW 264.7 cells. Life Sci 76: 2315-2328, 2005.
3. Makarov SS: NF-kappa B as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6: 441-448, 2000.
4. Xie Q and Nathan C: The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 56: 576-582, 1994. (Pubitemid 24348815)
5. Titheradge MA: Nitric oxide in septic shock. Biochim Biophys Acta 1411: 437-455, 1999.
6. Zamora R, Vodovotz Y and Billiar TR: Inducible nitric oxide synthase and inflammatory diseases. Mol Med 6: 347-373, 2000.
7. Noh EJ, Ahn KS, Shin EM, Jung SH and Kim YS: Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7 macrophages. Life Sci 79: 695-701, 2006. (Pubitemid 43927982)
8. Xie QW, Kashiwabara Y and Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994. (Pubitemid 24239438)
9. Lowenstein CJ, Alley EW, Raval P, et al: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734, 1993. (Pubitemid 23315860)
10. Rice NR and Ernst MK: In vivo control of NF-κB activation by IκBα. EMBO J 12: 4685-4695, 1993.
11. McKay DL and Blumberg JB: A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L) Phytother Res 20: 519-530, 2006.
12. Srivastava JK and Gupta S: Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55: 9470-9478, 2007.
13. Speisky H, Rocco C, Carrasco C, Lissi EA and López-Alarcón C: Antioxidant screening of medicinal herbal teas. Phytother Res 20: 462-467, 2006.
14. Ganzera M, Schneider P and Stuppner H: Inhibitory effects of the essential oil of chamomile (Matricaria recutita) and its major constituents on human cytochrome P450 enzymes. Life Sci 78: 856-861, 2006.
15. Ross SM: Chamomile: a spoonful of medicine. Holist Nurs Pract 22: 56-57, 2008.
16. Babenko NA and Shakhova EG: Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats. Exp Gerontol 41: 32-39, 2006.
17. Lee KG and Shibamoto T: Determination of antioxidant potential of volatile extracts isolated from various herbs and spices. J Agric Food Chem 50: 4947-4952, 2002.
18. Srivastava JK and Gupta S: Health promoting benefits of chamomile in the elderly population. In: Complementary and Alternative Therapies in the Aging Population. Watson, Ronald R, (eds.). Elsevier Inc., Academic Press, San Diego, 2009.
19. Srivastava JK, Pandey M and Gupta S: Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci 85: 663-669, 2009.
20. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
21. Shukla S, MacLennan GT, Fu P, et al: Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6: 390-400, 2004.
22. Adams DO and Hamilton TA: The cell biology of macrophage activation. Annu Rev Immunol 2: 283-318, 1984.
23. Choi MS, Lee SH, Cho HS, et al: Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide- treated RAW 264.7 cells. Eur J Pharmacol 556: 181-189, 2007.
24. Park JS, Lee JH and Ha TY: Effects of capsaicin pretreatment on the function of mouse peritoneal macrophages. Kor J Immunol 22: 39-49, 2000.
25. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR: TIS10, a phorbol ester tumor promoterinducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 12866-12872, 1991.
26. Baeuerle PA and Baltimore D: NF-kappa B: ten years after. Cell 87: 13-20, 1996.
27. Zhou HY, Shin EM, Guo LY, et al: Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation. Eur J Pharmacol 586: 340-349, 2008.
28. Ballard DW, Dixon EP, Peffer NJ, et al: The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89: 1875-1879, 1992.
29. Schmitz ML and Baeuerle P: The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 10: 3805-3817, 1991.
30. Vermeulen L, DeWilde G, Notebaert S, Vanden Berghe W and Haegeman G: Regulation of the transcriptional activity of the nuclear factor kappaB p65 subunit. Biochem Pharmacol 64: 963-970, 2002. (Pubitemid 35232270)
31. Zhong H, May MJ, Jimi E and Ghosh S: The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002. (Pubitemid 34273792)